A new report from the National Academies of Sciences, Engineering, and Medicine recommends two frameworks that medical professional societies, health care organizations, and state, national and local agencies could use to develop clinical practice guidelines for prescribing opioids to manage acute pain. Requested by the Food and Drug Administration, the report also identifies surgical procedures and acute medical conditions for which evidence-based guidelines would be desirable. Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research, said the agency will consider the recommendations as it develops evidence-based prescribing guidelines for treating acute pain in therapeutic areas for which guidelines do not exist.

Headline
The second listening session in the AHA’s series on disability health will focus on community partnerships and is scheduled for Oct. 28 at 1 p.m. ET. These…
Headline
In this conversation, Brian Peters, CEO of the Michigan Health & Hospital Association, explores the connection between health disparities, healthcare costs…
AHA Cyber Intel
While we may feel inundated with alarming news about escalating cyber threats against healthcare organizations, there is also some good news. Let’s explore how…
Headline
The Food and Drug Administration released draft guidance Sept. 24 that includes recommendations on non-clinical testing, clinical data and labeling for…
Headline
The AHA will host a webinar on Nov. 12 at 2 p.m. ET exploring the AHA’s Economic Impact of Disparities in Health Outcomes Resource Guide which helps hospital…
Headline
A multistate cyclospora outbreak linked to iceberg lettuce has been declared over, the Centers for Disease Control and Prevention and Food and Drug…